热门资讯> 正文
ADC Therapeutics宣布1亿美元私人融资
2025-06-12 19:32
- Informatica Inc.(NYSE) 0
- ADC Therapeutics SA(ADCT) 0
- Invesco Actively Managed Exchange-Traded Fund Trust Invesco SteelPath MLP & Energy Infrastructure ETF(PIPE) 0
- ADC Therapeutics (NYSE:ADCT) has entered into securities purchase agreements for the sale of its equity securities to certain institutional investors in a $100M private investment in public equity ("PIPE”) financing.
- The company is selling 13M common shares at $3.53 a share and pre-funded warrants to purchase 15.7M common shares at $3.43 per pre-funded warrant.
- Gross proceeds from the financing are anticipated to be ~$100M, extending the company’s expected cash runway into 2028.
- ADC Therapeutics plans to use the net proceeds to fund multiple catalysts primarily in support of ZYNLONTA clinical development as well as ZYNLONTA commercialization activities, working capital and general corporate purposes.
- The PIPE is expected to close on June 16, 2025, subject to customary closing conditions.
- Source: Press Release
More on ADC Therapeutics
- ADC Therapeutics SA (ADCT) Q1 2025 Earnings Call Transcript
- ADC Therapeutics SA 2025 Q1 - Results - Earnings Call Presentation
- ADC Therapeutics SA (ADCT) Q4 2024 Earnings Call Transcript
- ADC Therapeutics signals data catalysts ahead with ZYNLONTA combinations, aims for regulatory milestones through 2025
- ADC Therapeutics Non-GAAP EPS of -$0.22, revenue of $23.03M beats by $5.32M
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
